Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB (GNS)
Primary Purpose
Bladder, Overactive
Status
Unknown status
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Genital Nerve Stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Bladder, Overactive
Eligibility Criteria
Inclusion Criteria:
- women >18y
- suffering form intractable iOAB
- proved iOAB by urodynamic testing
- non pregnant
- good health
- patients demanding for therapy of iOAB and willing taking part to the study
- >6-9 months from last therapy with botulinum toxine A
Exclusion Criteria:
- pregnancy
- patients affected by a neurogenic condition
- any health condition being a contraindication for the procedure
Sites / Locations
- Possover
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Genital Nerve Stimulation
Arm Description
Stimulation of the DNP
Outcomes
Primary Outcome Measures
Frequency of bladder voiding
Patient's report on frequency of micturition
Secondary Outcome Measures
Safety of the GNS procedure
Record of all pre- and postoperative complications
Full Information
NCT ID
NCT04160793
First Posted
October 18, 2019
Last Updated
November 8, 2019
Sponsor
Prof. Dr. med. Marc Possover
1. Study Identification
Unique Protocol Identification Number
NCT04160793
Brief Title
Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB
Acronym
GNS
Official Title
Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB
Study Type
Interventional
2. Study Status
Record Verification Date
November 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2020 (Anticipated)
Primary Completion Date
July 31, 2020 (Anticipated)
Study Completion Date
August 1, 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Prof. Dr. med. Marc Possover
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The Genital Nerve Stimulation - GNS - consists of a two-step procedure with a preoperative non-surgical test-phase and a final surgical implantation of the neuroprothesis. In contrast to the classical technique of transcutaneous lead electrode implantation for sacral or pudendal nerve stimulation, the GNS-test-phase does not require any interventional procedure: because the genital nerves are located just few millimeter below the skin, test-stimulation can be achieved using skin surface or needle electrodes. Stimulation is achieved using a battery powered hand-held stimulator . The effect of the stimulation can be tested by the patient in their daily, home and professional environment, or at the practice under urodynamic testing, or if required other electrophysio-logical testing. After confirmation of the effectiveness of GNS, implantation of a permanent neuroprothesis can be planned. The procedure is performed either under general or spinal anesthesia or using only local anesthesia with IV-sedation as in the classical tension-free vaginal tape procedure (TVT). Because the GNS does not require two surgical procedures for both the test- and the final-implantation but rather only one for the final implantation, the presented protocol allows considerable cost reduction in comparison to the usual procedures for sacral or pudendal nerve stimulation.
Detailed Description
Pelvic organ dysfunctions are complex and difficult to treat. These conditions affect a substantial portion of the population, especially with increasing age. The two most frequent pelvic dysfunctions are the idio-pathic overactive bladder (IOAB) and erectile dysfunction (ED).
In pelvic dysfunctions, sacral nerve stimulation was the first technique for pelvic nerves stimulation that typically involves electrical stimulation of the nerve via a dorsal transformational technique of implantation. SNS evolved as a widely used treatment for OAB but does not completely resolve symptoms in the majority of patients. Because PNS reach more "sphincter-vesico-anal" fibers than SNM, PNS has been proposed for patients who have failed to respond to sacral neuromodulation. The good effects of PNS in neurogenic and in some non-neurogenic disorders. However, the implantation of a lead to the PN is not easily accomplished and the risk for lead migration with implantation below the pelvic floor is increased. So there is definitively a need for a more suitable alternative for selective stimulation within the pelvic cavity, a method that cannot only be reserved for experts in this field but for all gynecologists dealing with patients suffering from functional disorders of the bladder in daily clinical practice. The stimulation of the dorsal nerve of the pe-nis/clitoris - GNS - emerges as a very attractive alternative that might result in great outcomes for controlling urinary and fecal disorders.
Because part of the DNP lies superficially to the skin outside the pelvis, this nerve can be stimulated using surface electrodes attached to the overlying skin of the penis or close to the clitoris. This application is however limited, due to intolerance to required high stimulation amplitude. Surface electrodes have limitations such as difficulties in proper daily placement and issues related to hygiene as well as a lack of acceptance in some patients. Implanted electrodes are more suitable. However, implanted electrodes in the penis or near the clitoris, must endure the mechanical stress of penile erections and external pressure, carrying the risk of the cable/electrode breaking or being dislocated.
The GNS consists of a two-step procedure with a preoperative non-surgical test-phase and a final surgical implantation of the neuroprothesis. In contrast to the classical technique of transcutaneous lead electrode implantation for sacral or pudendal nerve stimulation, the GNS-test-phase does not require any interventional procedure: because the genital nerves are located just few millimeter below the skin, test-stimulation can be achieved using skin surface or needle electrodes. Stimulation is achieved using a battery powered hand-held stimulator . The effect of the stimulation can be tested by the patient in their daily, home and professional environment, or at the practice under urodynamic testing, or if required other electro-physiological testing. After confirmation of the effectiveness of GNS, implantation of a permanent neuroprothesis can be planned. The procedure is performed either under general or spinal anesthesia or using only local anesthesia with IV-sedation as in the classical tension-free vaginal tape procedure (TVT). Because the GNS does not require two surgical procedures for both the test- and the final-implantation but rather only one for the final implantation, the presented protocol allows considerable cost reduction in comparison to the usual procedures for sacral or pudendal nerve stimulation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder, Overactive
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Prospective unblinded interventional study
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Genital Nerve Stimulation
Arm Type
Other
Arm Description
Stimulation of the DNP
Intervention Type
Device
Intervention Name(s)
Genital Nerve Stimulation
Intervention Description
Implantation the vaginal way a stimulation's electrode to the dorsal nerve of the clintoris in local anesthesia
Primary Outcome Measure Information:
Title
Frequency of bladder voiding
Description
Patient's report on frequency of micturition
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Safety of the GNS procedure
Description
Record of all pre- and postoperative complications
Time Frame
6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
women >18y
suffering form intractable iOAB
proved iOAB by urodynamic testing
non pregnant
good health
patients demanding for therapy of iOAB and willing taking part to the study
>6-9 months from last therapy with botulinum toxine A
Exclusion Criteria:
pregnancy
patients affected by a neurogenic condition
any health condition being a contraindication for the procedure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marc Possover, PhD, MD
Phone
+41 44 520 3600
Email
m.possover@possover.com
First Name & Middle Initial & Last Name or Official Title & Degree
Fiona Muir
Phone
+41 44 520 3604
Email
f.muir@possover.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marc Possover, PhD, MD
Organizational Affiliation
PIMC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Possover
City
Zürich
ZIP/Postal Code
8008
Country
Switzerland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marc Possover, MD, PhD
Phone
+41 44 520 3600
Email
m.possover@possover.com
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
22865209
Citation
Farag FF, Martens FM, Rijkhoff NJ, Heesakkers JP. Dorsal genital nerve stimulation in patients with detrusor overactivity: a systematic review. Curr Urol Rep. 2012 Oct;13(5):385-8. doi: 10.1007/s11934-012-0273-x.
Results Reference
result
PubMed Identifier
21788054
Citation
Martens FM, Heesakkers JP, Rijkhoff NJ. Surgical access for electrical stimulation of the pudendal and dorsal genital nerves in the overactive bladder: a review. J Urol. 2011 Sep;186(3):798-804. doi: 10.1016/j.juro.2011.02.2696. Epub 2011 Jul 23.
Results Reference
result
Learn more about this trial
Genital Nerve Stimulation - GNS - for Treatment of Non-neurogenic OAB
We'll reach out to this number within 24 hrs